$1.9 Billion is the total value of Novo Holdings A/S's 51 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BAM | BROOKFIELD ASSET MGMT INCcl a ltd vt sh | $165,251,000 | -6.3% | 2,921,171 | 0.0% | 8.72% | +4.4% | |
| BSX | BOSTON SCIENTIFIC CORP | $153,402,000 | +4.3% | 3,463,577 | 0.0% | 8.09% | +16.1% | |
| BABA | ALIBABA GROUP HLDG LTDsponsored ads | $54,490,000 | -8.4% | 500,827 | 0.0% | 2.87% | +2.0% | |
| EWTX | EDGEWISE THERAPEUTICS INC | $54,196,000 | -36.5% | 5,587,207 | 0.0% | 2.86% | -29.3% | |
| INGN | INOGEN INC | $34,778,000 | -4.6% | 1,072,735 | 0.0% | 1.84% | +6.3% | |
| FOLD | AMICUS THERAPEUTICS INC | $24,245,000 | -18.0% | 2,560,211 | 0.0% | 1.28% | -8.6% | |
| CABO | CABLE ONE INC | $23,242,000 | -17.0% | 15,873 | 0.0% | 1.23% | -7.5% | |
| CYT | CYTEIR THERAPEUTICS INC | $18,248,000 | -66.8% | 4,840,413 | 0.0% | 0.96% | -63.0% | |
| IO BIOTECH INC | $17,373,000 | -17.2% | 3,277,932 | 0.0% | 0.92% | -7.8% | ||
| LVTX | LAVA THERAPEUTICS NV | $14,640,000 | -20.0% | 3,327,312 | 0.0% | 0.77% | -10.9% | |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | $13,928,000 | -12.8% | 836,518 | 0.0% | 0.74% | -2.8% | |
| BOLT | BOLT BIOTHERAPEUTICS INC | $12,341,000 | -44.1% | 4,503,991 | 0.0% | 0.65% | -37.7% | |
| SPNE | SEASPINE HLDGS CORP | $10,442,000 | -10.7% | 858,752 | 0.0% | 0.55% | -0.5% | |
| RPHM | RENEO PHARMACEUTICALS INC | $10,085,000 | -65.6% | 3,430,377 | 0.0% | 0.53% | -61.7% | |
| RCKT | ROCKET PHARMACEUTICALS INC | $9,719,000 | -27.4% | 612,822 | 0.0% | 0.51% | -19.0% | |
| TMCI | TREACE MED CONCEPTS INC | $9,463,000 | +1.4% | 500,421 | 0.0% | 0.50% | +12.9% | |
| PHVS | PHARVARIS N V | $9,366,000 | +26.1% | 516,321 | 0.0% | 0.49% | +40.3% | |
| SPRB | SPRUCE BIOSCIENCES INC | $9,074,000 | -54.9% | 4,514,336 | 0.0% | 0.48% | -49.7% | |
| GRTX | GALERA THERAPEUTICS INC | $5,852,000 | -48.2% | 2,459,021 | 0.0% | 0.31% | -42.1% | |
| GLTO | GALECTO INC | $5,495,000 | -27.4% | 2,497,791 | 0.0% | 0.29% | -19.0% | |
| AKUS | AKOUOS INC | $5,044,000 | -44.1% | 1,061,990 | 0.0% | 0.27% | -37.7% | |
| MQ | MARQETA INC | $4,875,000 | -35.7% | 441,558 | 0.0% | 0.26% | -28.4% | |
| SPRO | SPERO THERAPEUTICS INC | $4,079,000 | -45.7% | 468,902 | 0.0% | 0.22% | -39.4% | |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $4,082,000 | -3.7% | 25,000 | 0.0% | 0.22% | +7.0% | |
| VRNA | VERONA PHARMA PLCsponsored ads | $3,798,000 | -25.7% | 761,205 | 0.0% | 0.20% | -17.4% | |
| PRAX | PRAXIS PRECISION MEDICINES I | $2,553,000 | -48.2% | 250,000 | 0.0% | 0.14% | -42.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2022-05-27
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INDEX FDS | 41 | Q3 2022 | 64.7% |
| INOGEN INC | 34 | Q2 2022 | 68.8% |
| VANGUARD INTL EQUITY INDEX F | 29 | Q4 2016 | 37.6% |
| AMICUS THERAPEUTICS INC | 22 | Q3 2023 | 4.1% |
| AKEBIA THERAPEUTICS INC | 21 | Q3 2020 | 4.8% |
| VERONA PHARMA PLC | 21 | Q2 2022 | 1.9% |
| CORVUS PHARMACEUTICALS INC | 20 | Q4 2020 | 7.1% |
| INSPIRE MED SYS INC | 20 | Q3 2023 | 1.8% |
| CABLE ONE INC | 19 | Q3 2023 | 9.7% |
| FLEXION THERAPEUTICS INC | 19 | Q3 2021 | 4.7% |
View Novo Holdings A/S's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cyteir Therapeutics, Inc. | August 03, 2023 | 1,547,136 | 4.4% |
| Disc Medicine, Inc. | June 28, 2023 | 1,090,772 | 4.8% |
| Galera Therapeutics, Inc. | June 28, 2023 | 2,100,000 | 4.9% |
| VectivBio Holding AGSold out | May 26, 2023 | 0 | 0.0% |
| LanzaTech Global, Inc. | February 17, 2023 | 15,814,845 | 8.1% |
| Bolt Biotherapeutics, Inc.Sold out | January 04, 2023 | 0 | 0.0% |
| Arcellx, Inc. | December 12, 2022 | 1,750,000 | 4.0% |
| MINERVA SURGICAL INC | November 03, 2022 | 1,322,473 | 4.5% |
| Milestone Pharmaceuticals Inc. | October 24, 2022 | 1,378,538 | 4.6% |
| Galecto, Inc. | September 30, 2022 | 2,497,791 | 9.8% |
View Novo Holdings A/S's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 4 | 2024-05-14 |
| SC 13G/A | 2024-05-14 |
| 144 | 2024-05-10 |
| SC 13D/A | 2024-03-28 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-20 |
| SC 13D/A | 2024-03-20 |
| 144 | 2024-03-18 |
View Novo Holdings A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.